Short answer
CTS CORP (CTS) filed its Q3 2026 10-Q quarterly report on Oct 27, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $150M (up 4.6% year over year) with net income of $18M.
Q3 2026 key financials · XBRL
- Revenue
- $150M
- +4.6% YoY · +3.3% QoQ
- Net income
- $18M
- +29.7% YoY · −7.3% QoQ
- Operating margin
- 17.1%
- Gross margin
- 42.2%
- EPS (diluted)
- $0.61
- +32.6% YoY · −9.0% QoQ
Source: XBRL data from the CTS CORP (CTS) Q3 2026 10-Q on SEC EDGAR. USD.
CTS CORP Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q3 revenue $149.6M, up 4.6% YoY from $143.0M, diversified markets up 6.6%
- Gross margin 42.2% vs 38.7%; operating margin 17.1% vs 14.7%
- Medical and industrial growth strongest; aerospace and defense declined on contract-award timing
- Cash $143.9M vs $82.3M at December 31; operating cash flow $94.3M through nine months
- Millar acquisition for $50.0M, up to $20.0M contingent consideration; tariffs, market softness and geopolitical risks remain headwinds
Risk Factors
- No material changes to risk factors from the December 31, 2025 Form 10-K
- Continued risks include competitive pressure, based on carried-forward disclosures
- Continued risks include regulatory and legal compliance exposure, based on carried-forward disclosures
- Continued risks include liquidity, debt, and market exposure, based on carried-forward disclosures
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other CTS CORP quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.